ModelEdge
Regeneron Pharmaceuticals, Inc.
REGN
Filing type
10-K
Filing date
Feb 3, 2026
Updated
Feb 4, 2026 ยท 7:08 AM

Filing

10-KFY 2024

Exhibits

EX-4.1DESCRIPTION OF SECURITIESEX-10.3 8FORM OF STOCK OPTION AWARD AGREEMENT - EXECUTIVE OFFICERSEX-10.3 9FORM OF RESTRICTED STOCK AWARD AGREEMENT - EXECUTIVE OFFICERSEX-10.3 10FORM OF RSU AWARD AGREEMENT - NON-EMPLOYEE DIRECTORSEX-21.1SUBSIDIARIES OF THE REGISTRANTEX-23.1CONSENT OF PRICEWATERHOUSECOOPERS LLPEX-31.1CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)EX-31.2CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)EX-32CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350GRAPHIC